Ensysce Biosciences, Inc. ( ENSC) - Key Metrics
ENSC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.17 | -$1.29 | -$0.65 | -$0.69 |
| 2025Q2 | $0.62 | -$0.79 | -$1.23 | -$1.23 |
| 2025Q1 | $0.94 | -$1.39 | -$1.22 | -$1.22 |
ENSC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -0.46 |
| 2025Q2 | ? | -0.71 |
| 2025Q1 | ? | -0.46 |
ENSC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -95.06% | ? |
| 2025Q4 | -64.86% | ? |
| 2025Q3 | -29.09% | ? |
| 2025Q2 | -55.12% | ? |
| 2025Q1 | -47.61% | ? |
ENSC
Price: $0.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 86482
Market Capitalization: 2.4 million